San Diego, Calif. – GemPharmatech played a prominent role at the BIOCHINA Global Forum held June 2 in San Diego, where nearly 200 leaders in biotechnology gathered to discuss international cooperation, innovation, and the future of global health. The event underscored China’s expanding influence in the biotech industry—and GemPharmatech’s leadership in shaping its international reach.

Dr. Brandy Wilkinson, CEO of GemPharmatech LLC, led a high-profile panel discussion titled “Review of Successful Cases of Collaboration Between China and International Partners,” spotlighting how cross-border partnerships have enabled Chinese pharmaceutical innovations to succeed in global markets. Drawing on GemPharmatech’s own collaborative approach and global presence, Dr. Wilkinson highlighted the company’s ongoing commitment to building bridges between the Chinese biotech ecosystem and international drug development partners.

“True innovation in life sciences comes from open collaboration,” Dr. Wilkinson said. “GemPharmatech is committed to advancing a model of scientific partnership that brings together global resources, knowledge, and capabilities—delivering better solutions for patients worldwide.”

During the session, panelists explored how Chinese and foreign companies can deepen cooperation during clinical-stage development, regulatory alignment, and commercialization. Several case studies illustrated the value of combining China’s strengths in preclinical modeling and early research with global expertise in clinical execution and market access—a model GemPharmatech continues to champion through its work with partners across North America, Europe, and Asia.

As a leading provider of genetically engineered mouse models (GEMMs) and preclinical services, GemPharmatech is uniquely positioned to support biopharmaceutical innovation across borders. With operations in both China and the United States, the company plays a central role in accelerating translational research and facilitating smoother pathways for global drug development.

The BIOCHINA Global Forum served as an important platform for furthering these goals, bringing together key stakeholders to align on shared challenges and opportunities in the biotech space. GemPharmatech’s active participation reflects its broader mission to serve as a trusted partner in the global life sciences community—building the next generation of therapeutic breakthroughs through strategic, cross-border collaboration.